Supplementary Financial Data (IFRS) for the Six Months Ended September 30, 2026
Filed with TSE · · 15 pages · English
Sumitomo Pharma Co.Ltd. on 6ix
In the deck
Earlier from Sumitomo Pharma Co.Ltd
- Notice Concerning Gain on Return of Retirement Benefit Trust (Extraordinary Income) Recorded in the Company’s Non-Consolidated Financial Statements
- Regarding a Report Concerning Sumitomo Pharma (The Company's Views on the GCR August 7 Report)
- Additional Explanation Regarding the Report “Sumitomo Chemical and Sumitomo Pharmaceutical: The 116 billion yen Swiss Shuffle”
- Regarding a Report Concerning Sumitomo Pharma
- Presentation Material (Conference on Q1 FY2026 Financial Results)
Later from Sumitomo Pharma Co.Ltd
All Sumitomo Pharma Co.Ltd news releasesFollow Sumitomo Pharma Co.Ltd into a list and get an email when it puts out news.
Follow Sumitomo Pharma Co.Ltd